v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net margin $ 63,301 $ 66,290
Adjustments to reconcile net margin to net cash provided by operating activities:    
Depreciation and amortization, including nuclear fuel 297,789 279,830
Accretion cost 29,139 36,039
Amortization of deferred gains (894) (894)
Allowance for equity funds used during construction (1,377) (763)
Deferred outage costs (23,434) (14,385)
Gain on sale of investments (183) (12,996)
Regulatory deferral of costs associated with nuclear decommissioning 3,455 1,368
Other (12,802) (25,989)
Change in operating assets and liabilities:    
Receivables (36,118) (45,037)
Inventories 17,009 11,573
Prepayments and other current assets (3,661) (9,517)
Accounts payable (27,233) (19,949)
Accrued interest 9,294 (3,671)
Accrued taxes (15,928) (15,711)
Other current liabilities (21,363) (6,174)
Rate management program billing credits applied (58,600) (66,056)
Other (3,460) 9,809
Total adjustments 151,633 117,477
Net cash provided by operating activities 214,934 183,767
Cash flows from investing activities:    
Property additions (388,104) (328,264)
Plant acquisition 0 (73,153)
Litigation proceeds received for capitalized spent nuclear fuel storage costs 21,684 0
Activity in nuclear decommissioning trust fund—Purchases (523,182) (713,412)
Activity in nuclear decommissioning trust fund—Proceeds 509,464 705,264
Activity in long-term and short-term investments—Purchases (126,191) (125,105)
Activity in long-term and short-term investments—Proceeds 198,503 194,546
Other (928) (1,419)
Net cash used in investing activities (308,754) (341,543)
Cash flows from financing activities:    
Long-term debt proceeds 418,435 362,442
Long-term debt payments (209,568) (207,124)
Decrease in short-term borrowings, net (173,887) (134,585)
Other (14,781) (39,725)
Net cash provided by (used in) financing activities 20,199 (18,992)
Net decrease in cash, cash equivalents and restricted cash (73,621) (176,768)
Cash, cash equivalents and restricted cash at beginning of period 338,313 490,592
Cash, cash equivalents and restricted cash at end of period 264,692 313,824
Cash paid for—    
Interest (net of amounts capitalized) 248,882 214,945
Supplemental disclosure of non-cash investing and financing activities:    
Change in asset retirement obligations 0 65,149
Accrued property additions at end of period $ 89,282 $ 22,693